Fit 4 Start alumni, Myelin-H has expanded its operations to the United States, where it recently opened a branch in New Boston.
Myelin-H, a pioneering Luxembourg company building a cutting-edge neuro technology solution to remotely monitor and treat brain disorders, starting with multiple sclerosis (MS), announced in August that it has expanded its operations to New Boston in the United States.
“Following a successful three-week business trip to the US, we are thrilled to announce that Myelin-H has officially landed in the United States! The office was incorporated during our trip to the US, which also included visits to our collaborators at Stanford Medicine in Palo Alto, NYU Langone Medical Center in New York City, and UC San Diego Health in San Diego, as well as visits to the Consulates General of Luxembourg in New York and San Francisco,” explains co-founder and COO Samaher Garbaya.
The American entity is now fully operational with its new office located at 265 Franklin St. Ste 1702, Boston, MA 02110.
The US office is important as we are on the cusp of commencing a multi-site clinical trial, with some of the major US hospitals and clinics working with us.” Samaher Garbaya, Co-founder and COO of Myelin-H
“During the business trip to the US, we also had the pleasure of participating in the Ascend conference in Las Vegas and sharing the stage with brilliant minds from Redwire Space, Axiom Space, Boryung, and Neursantys. We had the opportunity to shine a light on how we are leveraging our medical BCI technology to monitor, train, and enhance astronauts’ cognitive abilities before, during, and after deep space missions,” she mentions.
Article by Startup Luxembourg